Mark A. Chilvers

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients.

Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.

Variation of Ciliary Beat Pattern in Three Different Beating Planes in Healthy Subjects.

Response.

To beat, or not to beat, that is question! The spectrum of ciliopathies.

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis.

Ciliary functional analysis: Beating a path towards standardization.

Performance of a Three-Tier (IRT-DNA-IRT) Cystic Fibrosis Screening Algorithm in British Columbia.